Systems and methods of blood-based therapies having a microfluidic membraneless exchange device
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61M-037/00
B32B-027/04
B32B-027/12
출원번호
UP-0776360
(2007-07-11)
등록번호
US-7588550
(2009-09-24)
발명자
/ 주소
Leonard, Edward F.
West, Alan C.
Shaplely, Nina C.
Tang, Zhongliang
출원인 / 주소
The Trustees of Columbia University in the City of New York
대리인 / 주소
Miles & Stockbridge P.C.
인용정보
피인용 횟수 :
23인용 특허 :
188
초록▼
The present invention is directed to devices, systems and methods for removing undesirable materials from a sample fluid by contact with a second fluid. The sample fluid flows as a thin layer adjacent to, or between, concurrently flowing layers of the second fluid, without an intervening membrane. I
The present invention is directed to devices, systems and methods for removing undesirable materials from a sample fluid by contact with a second fluid. The sample fluid flows as a thin layer adjacent to, or between, concurrently flowing layers of the second fluid, without an intervening membrane. In various embodiments, a secondary separator is used to restrict the removal of desirable substances and effect the removal of undesirable substances from blood. The invention is useful in a variety of situations where a sample fluid is to be purified via a diffusion mechanism against an extractor fluid. Moreover, the invention may be used for the removal of components from a sample fluid that vary in size. When blood is the sample fluid, for example, this may include the removal of 'small' molecules, 'middle' molecules, macromolecules, macromolecular aggregates, and cells, from the blood sample to the extractor fluid.
대표청구항▼
The invention claimed is: 1. A method of performing a blood treatment, comprising: along a microfluidic channel, placing blood from a patient in direct contact with an extraction fluid, without mixing, such that blood proteins and uremic toxins move from the blood into the extraction fluid; moving
The invention claimed is: 1. A method of performing a blood treatment, comprising: along a microfluidic channel, placing blood from a patient in direct contact with an extraction fluid, without mixing, such that blood proteins and uremic toxins move from the blood into the extraction fluid; moving the extraction fluid out of contact with the blood at an end of the channel and into contact with a membrane at a pressure, and thereby passing water and uremic toxins in the extraction fluid through the membrane at a pressure sufficient to concentrate the blood proteins in a fraction of the extraction fluid and placing the resulting fraction in direct contact with the blood at a beginning of the channel, a recirculation of extraction fluid resulting in a concentration of blood proteins such that blood proteins are returned to the blood in the channel by diffusion. 2. The method of claim 1, wherein the placing includes preventing cells from moving from the blood into the extraction fluid. 3. The method of claim 1, wherein the placing includes flowing the blood and extraction fluid through the microfluidic channel, the channel having a ratio of width (the dimension perpendicular to flow direction and parallel to the interface between the blood and extraction fluid) and height (the direction normal to the interface between the blood and extraction fluid) that is more than 10. 4. The method of claim 3, wherein the placing includes flowing the blood and extraction fluid through the microfluidic channel, which has a ratio of width to height that is more than 50. 5. The method of claim 3, wherein the channel height is less than 100 microns. 6. The method of claim 1, wherein the extraction fluid includes dialysate. 7. The method of claim 6, wherein the placing includes creating a laminar flow of the blood and extraction fluids including two layers of extraction fluid with a blood layer sandwiched between them. 8. The method of claim 1, wherein the placing includes creating a laminar flow of the blood and extraction fluids. 9. The method of claim 1, wherein the placing includes creating a laminar flow of the blood and extraction fluids including two layers of extraction fluid with a blood layer sandwiched between them; the flow being created in the microfluidic channel, which has a ratio of width (the dimension perpendicular to flow direction and parallel to the interface between the blood and extraction fluid) to height (the direction normal to the interface between the blood and extraction fluid) of more than 10 and has a height of less than 100 microns. 10. The method of claim 1, wherein the placing includes creating a laminar parallel flow of the blood and extraction fluids including two layers of extraction fluid with a blood layer sandwiched between them, the total volume flow rate of blood and the total volume flow rate of extraction fluid being approximately the same. 11. The method of claim 1, wherein the placing includes creating a laminar flow of the blood and extraction fluids including two layers of extraction fluid and a blood layer sandwiched between them, the total volume flow rate of blood in the blood layer and the total volume flow rate of extraction fluid in the two extraction fluid layers being approximately the same. 12. The method of claim 1, wherein the passing includes circulating the extraction fluid across a single side of the membrane without passing it through the membrane such that the resulting fraction is depleted of water and uremic toxins. 13. The method of claim 1, wherein the placing includes pumping the extraction fluid using a first pump and pumping the blood using a second pump. 14. The method of claim 1, wherein the placing includes flowing the blood and extraction fluid to form a flat blood layer such that blood cells tend to drift toward a center of the blood layer. 15. The method of claim 1, wherein the placing includes flowing the blood and extraction fluid to form a flat blood layer and at least one extraction fluid layer, the combined blood layer and at least one extraction fluid layer defining a velocity profile in which the blood layer coincides with a region of minimum shear rate such that cells tend to remain in the blood layer as a result of a tendency of cells to migrate away from high shear rate regions of a flow. 16. The method of claim 1, wherein the placing includes creating a laminar parallel flow between walls of the microfluidic channel that includes two layers of extraction fluid with a blood layer sandwiched between them, the flow being such that the cells within the blood layer do not contact the walls. 17. A method of performing a blood treatment, comprising: establishing a flow of blood and extraction fluid in a channel such that the blood and extraction fluid are in direct contact and such that entering and exiting flows of each of the blood and extraction fluid into and from the channel are established, respectively, at opposing ends of the channel, the exiting flow of extraction fluid containing blood proteins diffused there into; conveying a portion of the extraction fluid in the extraction fluid exiting flow to the extraction fluid entering flow and further passing the extraction fluid portion across a membrane at a pressure such as to expel water and uremic toxins therethrough; and permitting proteins to concentrate in the extraction fluid such that a quantity of the blood proteins leaving the channel in the extraction fluid exiting flow is substantially equal to the quantity of the blood proteins returned to the channel entering flow. 18. The method of claim 17, wherein the establishing includes retaining blood cells in the blood exiting flow and preventing them from leaving in the extraction fluid exiting flow by maintaining a lower shear rate at a location of the channel coinciding with the blood exiting flow than a shear rate at one or more locations of the channel coinciding with the extraction fluid exiting flow. 19. A method of performing a blood treatment, comprising: flowing blood and dialysate into a microfluidic channel such that the blood and dialysate are in direct contact but remain in separate layers in the channel; the flowing being such that a lower shear rate is maintained in the blood layer than a shear rate maintained in one or more dialysate layers, the difference in shear rate being sufficient to cause blood cells to be retained in the blood layer while permitting blood proteins and uremic toxins to diffuse into the one or more dialysate layers; passing dialysate exiting the channel across one side of a membrane at a pressure such that water and uremic toxins flow through the membrane and out of the dialysate while preventing blood proteins from passing through the membrane thereby retaining the blood proteins in the dialysate such that the blood proteins concentrate in the dialysate and thereafter returning the dialysate and blood proteins back to the channel such that blood proteins are returned to the blood in the channel. 20. A method of performing a blood treatment, comprising: passing, through a channel, blood from a patient and an extraction fluid, such that the blood and extraction fluid are in direct contact without mixing, the channel being configured such that substantial quantities of albumin and uremic toxins move from the blood into the extraction fluid; placing the extraction fluid in contact with a membrane under pressure and, as a result, passing water and uremic toxins in the extraction fluid through the membrane; placing processed extraction fluid in direct contact with blood; and permitting the albumin to concentrate in the extraction fluid such that the substantial quantities of albumin are returned to the blood in the placing, wherein the flow of blood and extraction fluid in the channel during the passing, and the configuration of the channel, are such that blood is isolated from the channel walls by the extraction fluid and such that upon exiting the channel, a quantity of urea in the blood is substantially the same as a quantity of urea in the extraction fluid. 21. The method of claim 20, wherein the placing processed extraction fluid in direct contact with blood includes passing the processed extraction fluid through the channel. 22. The method of claim 20, wherein the placing processed extraction fluid in direct contact with blood includes passing the processed extraction fluid through the channel and the secondary treatment device is a membrane and the passing therethrough is effective to concentrate the albumin in a fraction of the extraction fluid. 23. A method of performing a blood treatment, comprising: passing, through a channel, blood from a patient and an extraction fluid such that the blood and extraction fluid are in direct contact, the channel being configured such that substantial quantities of albumin and uremic toxins move from the blood into the extraction fluid; removing the extraction fluid from the channel and flowing the extraction fluid on a side of a membrane, while providing a transmembrane pressure, and thereby passing water and uremic toxins in the extraction fluid through the membrane to concentrate the albumin in a fraction of the extraction fluid and returning at least a portion of the fraction back to the channel to be passed again therethrough in direct contact with blood, such that albumin is concentrated in the blood and thereby returned to the blood, wherein the flow of blood and extraction fluid in the channel during the passing and the configuration of the channel are such that blood is isolated from the channel walls by the extraction fluid and such that, upon exiting the channel, a quantity of urea in the blood is substantially the same as a quantity of urea in the extraction fluid. 24. A method of performing a blood treatment, comprising: placing blood and an extraction fluid in non-mixing direct contact to produce a resulting extraction fluid containing non-cellular components, including albumin, transferred from the blood into the second extraction fluid; removing the resulting extraction fluid from contact with the blood; subjecting the resulting extraction fluid to a medical process including flowing the resulting extraction fluid alone a membrane with a transmembrane pressure sufficient to ultrafilter the resulting extraction fluid such that albumin is concentrated therein; and placing the ultrafiltered extraction fluid back in direct contact with the blood such that at least the albumin is returned to the blood by diffusion resulting from the concentration of the at least the albumin in the ultrafiltered extraction fluid. 25. The method of claim 24, wherein the concentration of albumin in the extraction fluid is permitted to increase to the point where it is approximately the same as a concentration of albumin in the blood. 26. The method of claim 24, wherein the placing the blood and an extraction fluid includes flowing the blood and the extraction fluid in a microfluidic channel.
Okuzumi Yuzi (Belle Mead NJ) Mellon A. Darline (Bridgewater NJ) Wasserman David (Springfield NJ), Addition copolymers of lactide and glycolide and method of preparation.
Wells John R. (Culver City CA) Grant John W. (Blacksburg VA), Apparatus for continuous separation of leukocyte/platelet-enriched fraction from whole blood.
Delcommune Luc (Monfalcone ITX) Ghyselinck Philippe (Braine-L\Alleud BEX), Article made of lactic acid polymer capable of being employed particularly as a biodegradable prosthesis and process for.
Calhoun Jason H. (Galveston TX) Mader Jon T. (Galveston TX), Biodegradable antibiotic implants and methods of their use in treating and preventing infections.
Tuan Rocky S. (Chester Springs PA) Lin Sheldon S. (Philadelphia PA), Biodegradable drug delivery system for the prevention and treatment of osteomyelitis.
Dunn Richard L. (451 Boardwalk Dr. RLD ; Apt. 501 Fort Collins CO 80526) English James P. (2500 Melinda Cir. Birmingham AL 35214) Cowsar Donald R. (4657 Round Forest Dr. Birmingham AL 35213) Vanderbi, Biodegradable in-situ forming implants and methods of producing the same.
Dunn Richard L. (Fort Collins CO) English James P. (Birmingham AL) Cowsar Donald R. (Birmingham AL) Vanderbilt David D. (Birmingham AL), Biodegradable in-situ forming implants and methods of producing the same.
Dunn Richard L. (Fort Collins CO) English James P. (Birmingham AL) Cowsar Donald R. (Birmingham AL) Vanderbilt David P. (Birmingham AL), Biodegradable in-situ forming implants and methods of producing the same.
Silver Frederick A. (Long Valley NJ) Berg Richard A. (Lambertville NJ) Birk David E. (Somerset NJ) Weadock Kevin (Piscataway NJ) Whyne Conrad (Somerset NJ), Biodegradable matrix and methods for producing same.
Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO) Southard George L. (Fort Collins CO) Rogers Jack A. (Fort Collins CO), Biodegradable system for regenerating the periodontium.
Kaplan, Donald S.; Hermes, Matthew; Muth, Ross R.; Kennedy, John, Blends of glycolide and/or lactide polymers and caprolactone and/or trimethylene carbonate polymers and absorbable surgical devices made therefrom.
Yao Shang J. (5 Bayard Road - Apt. 920 Pittsburgh PA 15213) Wolfson Sidney K. (205 Buckingham Road Pittsburgh PA 15215), Blood and tissue detoxification apparatus.
Greenwood Roger N. (London GBX) Aldridge Colin (London GBX) Tattershall James E. (London GBX) Barrett Rodney V. (Bristol GBX), Blood purification apparatus.
Jefferies Steven R. (5802 Leith Walk Baltimore MD 21239) Gutmann James L. (10112 Daventry Dr. Cockeysville MD 21030) Heatfield Barry M. (33 Penny La. Baltimore MD 21209), Collagen-enzyme conjugates that exhibit no inflammatory response and method for making the same.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Collagen-polymer conjugates.
Wozney John M. (Hudson MA) Wang Elizabeth A. (Carlisle MA) Rosen Vicki A. (Brookline MA) Celeste Anthony J. (Hudson MA), DNA sequences encoding BMP-6 proteins.
Muchow David C. (Transit Township ; Sibley County MN) Sirvio Larry M. (Cottage Grove MN), Device and method for extended delivery of pharmacologically active agents to the ear.
Weitzel, William Frederick; Humes, H. David; Paganini, Emil Presley; Buffington, Deborah Ann; Funke, Angela J., Extracorporeal fluid circuit and related methods.
Loughnane Michael H. (Lafayette Hill PA) Wiesmann William P. (Bethesda MD) Pearce Frederick J. (Olney MD) Kearney George P. (Durham NC), High effieciency balanced oscillating shuttle pump.
Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO) Harkrader Ronald J. (Louisville CO) Rogers Jack A. (Fort Collins CO), Intragingival delivery systems for treatment of periodontal disease.
Rutherford Robert B. (Farmington CT), Issue repair and regeneration through the use of platelet derived growth factor (PDGF) in combination with dexamethasone.
Trml Pertti (Reikonkatu 7 C 7 SF-33730 Tampere FIX) Vainionp Seppo (Orapihlajatie 21-27 B 12 SF-00320 Helsinki FIX) Rokkanen Pentti (Marjaniemenranta 29 SF-00930 Helsinki FIX) Helevirta Pertti (Ojava, Layered surgical biocomposite material.
Tang Reginald T. (Warren NJ) Mares Frank (Whippany NJ) Boyle ; Jr. William J. (Parsippany NJ) Chiu Tin-Ho (Millburn NJ) Patel Kundanbhai M. (Landing NJ), Medical devices fabricated totally or in part from copolymers of recurring units derived from cyclic carbonates and lact.
Wahlig Helmut (Darmstadt DEX) Dingeldain Elvira (Dreieich DEX) Braun Dietrich (Darmstadt-Arheilgen DEX), Medicinally useful, shaped mass of collagen resorbable in the body.
Peyman Gholam A. (123 Walnut St. New Orleans LA 70118), Method and apparatus for controlled release drug delivery to the cornea and anterior chamber of the eye.
March Keith L. (Carmel IN) Hathaway David R. (Indianapolis IN) Wilensky Robert L. (Indianapolis IN), Method for delivery of smooth muscle cell inhibitors.
Hermes Matthew E. (Easton CT) Muth Ross R. (Brookfield CT), Method for improving the storage stability of a polymeric article susceptible to hydrolytic degradation and resulting ar.
Rutherford Robert B. (Farmington CT) Charette Marc F. (Needham MA), Method for promoting tissue repair and regeneration using PDGF and glucocorticoids.
Tice Thomas R. (Birmingham AL) Dillon Deborah L. (Helena AL) Mason David W. (Birmingham AL) McRae-McFarlane Amanda (Vastra Frolunda SEX) Dahlstrom Annica B. (Askin SEX), Method for stimulating nerve fiber growth.
Stange Jan,DEX ; Mitzner Steffen,DEX ; Ramlow Wolfgang,DEX, Method for the separation of protein-bound substances from a protein-containing liquid by dialysis.
Brizzolara Nancy S. (Congers NY) Lanzilotti Michael G. (Pearl River NY) Lawter James R. (Goshen NY), Method for the treatment of periodontal disease by sustained delivery of a therapeutic agent to the periodontal pocket,.
Yelick, Pamela C.; Bartlett, John D.; Vacanti, Joseph P.; Olsen, Bjorn R.; Stashenko, Phillip, Methods and compositions for culturing a biological tooth.
Tung Ming S. (15233 Falconbridge Ter. Gaithersburg MD 20878), Methods and compositions for mineralizing and/or fluoridating calcified tissues with amorphous strontium compounds.
Mueth,Daniel M.; Anderson,Amy; Shireman,Jessica, Multiple laminar flow-based rate zonal or isopycnic separation with holographic optical trapping of blood cells and other static components.
Vert Michel (Deville-les-Rouen FRX) Chabot Francois (Rouen FRX) Leray Jean (Sevres FRX) Christel Pascal (Paris FRX), New prosthesis parts, their preparation and their application.
Mathiowitz Edith (Brookline MA) Langer Robert S. (Somerville MA) Warshawsky Abraham (Rehovot MA ILX) Edelman Elazar (Brookline MA), Polymer composite for controlled release or membrane formation.
DeLuca Patrick P. (Lexington KY) Kanke Motoko (Fukuyama JPX) Sato Toyomi (Tokyo CA JPX) Schroeder Hans G. (Encinitas CA), Porous microspheres for drug delivery and methods for making same.
Kaplan Donald S. (Weston CT) Hermes Matthew E. (Norwalk CT) Muth Ross R. (Brookfield CT) Kennedy John J. (Stratford CT), Process for making a surgical device using two-phase compositions.
Sherman John D. ; Bem David S. ; Lewis Gregory J., Process for removing toxins from bodily fluids using zirconium or titanium microporous compositions.
Kolff Willem J. (Salt Lake City UT) Shettigar Udipi R. (Salt Lake City UT), Process for therapeutic dissociation of immune complexes and removal of antigens.
Kaplan Donald S. (Weston CT) Hermes Matthew E. (Norwalk CT) Muth Ross R. (Brookfield CT) Kennedy John J. (Stratford CT), Process of making an absorbable surgical device.
Weigl Bernhard H. ; Holl Mark R. ; Zebert Diane ; Kenny Margaret ; Wu Caicai, Simultaneous analyte determination and reference balancing in reference T-sensor devices.
Zagoskin, Alexandre M.; Rose, Geordie; Amin, Mohammad H. S.; Franz, Marcel; Hilton, Jeremy P., Superconducting dot/anti-dot flux qubit based on time-reversal symmetry breaking effects.
Jamiolkowski Dennis D. (Long Valley NJ) Gaterud Mark T. (Annandale NJ) Newman ; Jr. Hugh D. (Chester NJ) Shalaby Shalaby W. (Lebanon NJ), Surgical fastener made from glycolide-rich polymer blends.
Smith Carl R. (Bloomingdale NJ) Gaterud Mark T. (Annandale NJ) Jamiolkowski Dennis D. (Long Valley NJ) Newman ; Jr. Hugh D. (Chester NJ) Shalaby Shalaby W. (Lebanon NJ), Surgical fastener made from glycolide-rich polymer blends.
Orsolini Piero (Martigny) Mauvernay Rolland-Yves (Lausanne) Deghenghi Romano (Lausanne CHX), Sustained and controlled release of water insoluble polypeptides.
Kaplan Donald S. (Weston CT) Hermes Matthew E. (Norwalk CT) Muth Ross R. (Brookfield CT) Kennedy John J. (Stratford CT), Two-phase compositions for absorbable surgical devices.
DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
Verhoef, Erik T.; DiPerna, Paul M.; Rosinko, Mike; Williamson, Mark; Kruse, Geoffrey A.; Ulrich, Thomas R.; Lamb, Phil; Saint, Sean; Michaud, Michael; Trevaskis, William, Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
Leonard, Edward F.; West, Alan C.; Shapley, Nina C.; Tang, Zhongliang, Methods of blood-based therapies having a microfluidic membraneless exchange device.
Leonard, Edward F.; West, Alan C.; Shapley, Nina C.; Tang, Zhongliang, Systems and methods of blood-based therapies having a microfluidic membraneless exchange device.
Leonard, Edward F.; West, Alan C.; Aucoin, Christian Paul; Nanne, Edgar E., Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.